Clinical Outcomes in Patients Undergoing Percutaneous Closure of Periprosthetic Paravalvular Leaks

Ruiz, Carlos E.; Jelnin, Vladimir; Kronzon, Itzhak; Dudiy, Yuriy; Valle, Raquel del; Einhorn, Bryce; Chiam, Paul T.L.; Martinez, Claudia; Eirós, Rocío; Roubin, Gary S.; Cohen, Howard A.

doi:10.1016/j.jacc.2011.03.074

Cited by 295 publications

(262 citation statements)

References 19 publications

Supporting

Mentioning

235

Contrasting

Unclassified

Order By: Relevance

“…Hourihan performed the first reported transcatheter closure of PVL in 1992 with double umbrella device and since then the technique is considerably developed [3]. Percutaneous PVL closure has been shown to be safe and effective treatment in different series [4,[5][6][7].…”

Section: Discussionmentioning

confidence: 99%

Transapical Paravalvular Leak Closure: A Case Report

Ilkay¹,

Tari²,

Canbay³

et al. 2017

Angiol

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Transapical Paravalvular Leak Closure: A Case Report

Ilkay¹,

Tari²,

Canbay³

et al. 2017

Angiol

View full text Add to dashboard Cite

show abstract

“…For this reason, when it comes to treating intermediate and low risk patients, the occurrence of "more than mild" PVL should unquestionably be avoided. Transcatheter devices specifically designed to solve PVL after TAVI are not currently available and results after closure with other kind of vascular occluders are suboptimal (22). New generation TAVI devices have already been engineered with specific novel features capable of reducing, but still not eliminating, PVL.…”

Section: Hemodynamic Performancementioning

confidence: 99%

Comparison of hemodynamic and clinical outcomes of transcatheter and sutureless aortic bioprostheses: how to make the right choice in intermediate risk patients

D’Onofrio

Fabozzo

Gerosa

2017

Ann. Cardiothorac. Surg.

View full text Add to dashboard Cite

Current surgical treatment options for aortic valve stenosis (AS), as alternatives to that of conventional operation with a midline sternotomy, include sutureless valve replacement (SUAVR) and transcatheter valve implantation (TAVI). Patients with high surgical risk, or those who are judged to be inoperable, are typically good candidates for the TAVI procedure. The best treatment option in patients with an intermediate risk profile, however, the so called "grey zone", is still currently under debate. Sutureless aortic valve replacement has been recently presented as a valid alternative for patients with low-to intermediate-risk. Data available on prostheses' hemodynamic performance and patients' clinical outcomes play a crucial role in the process of device selection. Compared to TAVI, SUAVR provides lower rate of significant postoperative paravalvular leak (PVL), which has shown to be a predictor for mortality. On the contrary, transcatheter valves seem to perform better in terms of transvalvular mean and peak gradients. Therefore, SUAVR and TAVI are both reliable options in patients with severe aortic valve stenosis, as an alternative to conventional surgery, and the choice of the best device should be tailored to patient's anatomical and surgical characteristics.

show abstract

“…1 Yet the presence of a mechanical aortic valve (AV) prosthesis has been considered a contraindication to retrograde percutaneous closure of a mitral paravalvular leak (MPVL). 2,3 In one case of MPVL with a mechanical AV prosthesis, 4 a retrograde approach was attempted but failed, because one of the discs of the prosthesis was repeatedly blocked as the catheter advanced through the AV prosthesis, which led to severe hemodynamic deterioration.…”

Section: Successful Casesmentioning

confidence: 99%

Retrograde Transcatheter Closure of Mitral Paravalvular Leak through a Mechanical Aortic Valve Prosthesis: 2 Successful Cases

Zhou¹,

Pan²,

Guan³

et al. 2016

Texas Heart Institute Journal

View full text Add to dashboard Cite

The presence of a mechanical aortic valve prosthesis has been considered a contraindication to retrograde percutaneous closure of mitral paravalvular leaks, because passing a catheter through the mechanical aortic valve can affect the function of a mechanical valve and thereby lead to severe hemodynamic deterioration. We report what we believe are the first 2 cases of retrograde transcatheter closure of mitral paravalvular leaks through a mechanical aortic valve prosthesis without transseptal or transapical puncture. Our experience shows that retrograde transcatheter closure of mitral paravalvular leaks in this manner can be an optional approach for transcatheter closure of such leaks, especially when a transapical or transseptal puncture approach is not feasible. This technique might also be applied to other transcatheter procedures in which there is a need to pass a catheter through a mechanical aortic valve prosthesis.

show abstract

Clinical Outcomes in Patients Undergoing Percutaneous Closure of Periprosthetic Paravalvular Leaks

Abstract: Percutaneous closure of symptomatic paravalvular leaks, facilitated by integrated imaging modalities has a high rate of acute and long-term success and appears to be effective in managing symptoms of heart failure and hemolytic anemia.

Cited by 295 publications

References 19 publications

Transapical Paravalvular Leak Closure: A Case Report

Transapical Paravalvular Leak Closure: A Case Report

Comparison of hemodynamic and clinical outcomes of transcatheter and sutureless aortic bioprostheses: how to make the right choice in intermediate risk patients

Retrograde Transcatheter Closure of Mitral Paravalvular Leak through a Mechanical Aortic Valve Prosthesis: 2 Successful Cases

Contact Info

Product

Resources

About